# NIDDM and IR in Combination Therapy for CHC

> **NCT00687999** · NA · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 400 (actual)

## Conditions studied

- Chronic Hepatitis C
- Insulin Resistance

## Interventions

- **DRUG:** pegylated interferon alpha and ribavirin

## Key facts

- **NCT ID:** NCT00687999
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2009-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687999, "NIDDM and IR in Combination Therapy for CHC". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00687999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*